Company: BIAF
Filing Date: 2025-12-19
Form Type: 8-K
Source: 0001493152-25-028584
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-12-19
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item
8.01. Other Events.

On
December 19, 2025, bioAffinity Technologies, Inc., a Delaware corporation (the “ Company”), convened and then determined to
adjourn, without conducting any business, a special meeting of stockholders (the “ Special Meeting”) because the Company did
not have a sufficient number of shares of the Company’s common stock present in person or represented by proxy at the Special Meeting
to constitute a quorum. The adjourned Special Meeting will reconvene on Monday, January 19, 2026, at 8:00 a. m. Central Time.

The
close of business on November 4, 2025, will continue to be the record date for determination of stockholders of the Company entitled
to vote at the Special Meeting. No changes have been made to the proposals to be voted on by the stockholders at the Special Meeting.
Stockholders who have previously submitted their proxy or otherwise voted and do not want to change their vote do not need to take any
action. Stockholders may cast their votes by following instructions set forth in the Company’s definitive proxy statement on Schedule
14A which was filed with the U. S. Securities and Exchange Commission (the “ SEC”) on November 7, 2025, which is available
on the SEC’s website at www. sec. gov

  -2-  

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K
to be signed on its behalf by the undersigned hereunto duly authorized.

  Date: December 19, 2025      BIOAFFINITY                                  
                               TECHNOLOGIES, INC.                           
 ────────────────────────────────────────────────────────────────────────────
                               By:                     /s/ Maria            
                               Name:                   Maria Zannes         
                               Title:                  President and Chief  

  -3-